Phage Therapy Researcher
Phage therapy researchers isolate, characterize, and formulate bacteriophages (viruses that specifically infect and kill bacteria) as targeted therapeutic interventions against multidrug-resistant (AMR) bacterial pathogens. In sub-Saharan Africa, where antimicrobial resistance is an escalating public health crisis threatening surgical outcomes and neonatal survival, they build curated phage biobanks, perform genomic sequencing to eliminate lysogenic toxin genes, and design customized phage cocktails to treat intractable clinical and veterinary infections. Emerging technological innovations across Kenyan industrial sectors continue to transform day to day operational workflows, elevating demand for skilled personnel who combine fundamental mastery with modern digital tool proficiencies.
The short answer
- Will AI take it
- 17 out of 100, low exposure. About 68% of the tasks still need a person.The detail
- Is anyone hiring
- Hiring is growing, with net demand +33% over 2024-2030.The detail
- What it pays
- Starts around KES 100k a month and reaches KES 890k at senior level.The detail
- How to get in
- KCSE C+ (Bachelor Degree) is the usual minimum, and 8 courses in the catalogue lead to it. About 5 years to a lead role.The detail
The role
What the work is, what it pays, and what it asks of you.
Overview
The field is rapidly developing through high-throughput genomic sequencing, transmission electron microscopy (TEM) virion profiling, and machine learning models predicting phage-receptor binding dynamics. As national medical institutions seek alternative biologics to combat superbugs, researchers must combine sterile laboratory microbiology with compassionate clinical trials and regulatory filings. Career progression advances from molecular microbiologist to lead phage researcher, biotherapeutics director, and clinical translational lead. In the Kenyan context, practitioners must adhere to national statutory frameworks, professional codes of ethics, and industry best practices established by relevant regulatory authorities. Employers increasingly prioritize candidates who demonstrate verified technical qualifications, continuous professional development, and practical problem solving competence.
The double-layer plaque purification protocols, viral genomic characterization procedures, and biosecurity safety standards are internationally harmonized, whether isolating therapeutic phages locally in Kenyan clinical laboratories, publishing infectious disease breakthroughs, or collaborating with global AMR consortia. Career advancement in Kenya typically rewards demonstrated operational reliability, enabling experienced professionals to transition into senior supervisory, quality assurance, or independent technical consulting roles across commercial and public enterprises.
Work environment
- Work environment
- Biosafety level 2+ microbiology laboratories, biomedical research institutes, university medical centers, and pharmaceutical facilities.
- Work style
- Experimental, microbiologically meticulous, safety focused, and research driven.
- Physical demands
- Moderate physical demand during sterile laboratory benchwork, pipetting, and centrifuge operations.
- Travel
- Minimal to moderate travel for field environmental sample collection across regional water bodies.
- Remote working
- On-site / field
- Freelance potential
- Low
A day in the role
Begins the morning screening environmental sewage and water samples using plaque assays to isolate novel lytic phages targeting antibiotic-resistant Klebsiella pneumoniae. Meets with clinical microbiologists at 11 AM to review whole-genome sequencing results confirming the absence of toxin genes. Spends the afternoon in the biosafety laboratory measuring phage burst size and host range kinetics against patient clinical isolates. You coordinate closely with cross functional colleagues to align on immediate deliverables, double checking equipment readiness and standard operating protocols. Throughout the shift, you document system performance metrics, consult with operational supervisors on technical exceptions, and uphold rigorous occupational health and environmental safety protocols.
In the afternoon, you execute core deliverables, consult with cross functional colleagues, document operational outcomes, and ensure that all equipment and handover notes are fully updated before completing the shift. Before completing the shift, you reconcile physical logs, review operational checklists with the oncoming team, archive incident reports, and brief project supervisors on task completion.
What it pays
Kenyan market salary bands, monthly in KES- Entry level
- KES 100k – 160k
- Mid-level specialist
- KES 210k – 410k
- Senior / lead
- KES 460k – 890k
Monthly pay in Kenyan shillings, rounded to the nearest thousand. The shaded band is the distance between entry and senior pay, which is the part that is changing. These are projections, not observations.
The trade-offs
| In its favour | Against it |
|---|---|
| Direct, life-saving impact providing the ultimate therapeutic cure against incurable antibiotic-resistant superbugs. | Host specificity challenge: an isolated phage that cures one patient may completely fail against another patient strain. |
| High international collaboration with leading phage biobanks and global antimicrobial resistance research consortiums. | Strict and slow regulatory approval frameworks for living viral biologicals under the Pharmacy and Poisons Board. |
| Deeply rewarding intersection of virology, evolutionary biology, clinical infectious disease, and genomic bioinformatics. | Endotoxin removal hurdles: purifying Gram-negative phages without residual toxic bacterial cell wall fragments. |
In practice
Phage Therapy Researcher in Kenya operates at the strategic intersection of specialized engineering, regional industrial transformation, and sustainable execution. As enterprise organizations, research institutes, and public utilities across East Africa modernize infrastructure, this role provides technical leadership, scalable architecture, and measurable operational resilience.
Core responsibilities encompass system architecture design, rigorous quality and safety assurance, cross-functional stakeholder collaboration, regulatory compliance with Kenyan and regional standards, and continuous performance telemetry monitoring.
Key organizations hiring for this role include Kenya Medical Research Institute (KEMRI), Institute of Primate Research (IPR), International Livestock Research Institute (ILRI), Kenya Science Consortium 4, alongside expanding opportunities in Nairobi, Mombasa, Kisumu, and regional infrastructure projects.
Phage Therapy Researcher Specialist, Senior Phage Therapy Researcher, Phage Therapy Researcher Lead, Phage Therapy Researcher Consultant
Exposure
How much of this a machine can already do, and how that was determined.
Where this rating sits
3,562 rated careers| Score | Careers |
|---|---|
| 0 to 4 | 29 |
| 5 to 9 | 22 |
| 10 to 14 | 116 |
| 15 to 19 | 290 |
| 20 to 24 | 542 |
| 25 to 29 | 297 |
| 30 to 34 | 305 |
| 35 to 39 | 195 |
| 40 to 44 | 253 |
| 45 to 49 | 279 |
| 50 to 54 | 264 |
| 55 to 59 | 156 |
| 60 to 64 | 101 |
| 65 to 69 | 130 |
| 70 to 74 | 128 |
| 75 to 79 | 151 |
| 80 to 84 | 163 |
| 85 to 89 | 86 |
| 90 to 94 | 54 |
| 95 to 99 | 1 |
Rated above 8% of the 3,562 careers in the catalogue, which averages 43. Inside science the mean is 37, across 151 careers.
What the rating is made of
Share of recorded tasks- Machine does it6%
- Software can already complete this work end to end.
- Machine assists26%
- A person still decides, but the drafting is done for them.
- Person does it68%
- Judgement, relationships and accountability that do not transfer.
Named task by task
Already automated
- Predict bacteriophage receptor-binding protein structures.
- Screen phage genomic sequences for antimicrobial resistance and toxin genes.
- Simulate bacterial mutation escape rates against multi-phage cocktails.
- Synthesize clinical efficacy trial pharmacokinetic models.
Still human
- Perform sterile environmental sample isolation and double-layer plaque purification assays.
- Conduct transmission electron microscopy (TEM) morphological characterization of viral capsids.
- Design personalized clinical phage cocktail ratios for compassionate-use treatment.
- Guide national regulatory approvals with the Pharmacy and Poisons Board (PPB).
| Already automated | Still human |
|---|---|
| Predict bacteriophage receptor-binding protein structures. | Perform sterile environmental sample isolation and double-layer plaque purification assays. |
| Screen phage genomic sequences for antimicrobial resistance and toxin genes. | Conduct transmission electron microscopy (TEM) morphological characterization of viral capsids. |
| Simulate bacterial mutation escape rates against multi-phage cocktails. | Design personalized clinical phage cocktail ratios for compassionate-use treatment. |
| Synthesize clinical efficacy trial pharmacokinetic models. | Guide national regulatory approvals with the Pharmacy and Poisons Board (PPB). |
Your skills, sorted
12 skills recordedBeing absorbed
- Manual physical counting of clear viral plaque zones on agar petri dishes
- Routine clerical typing of phage plaque forming unit (PFU) numbers into laboratory logs
- Standard manual downloading of Sanger sequencing electropherogram trace files
- Basic manual sorting of cryogenic freezer biobank storage cryovials
Worth more with the tools
- Machine learning prediction of phage-host interactions and receptor binding affinities from genomic sequences
- Automated prophage sequence detection ensuring isolated therapeutic phages lack toxin or antibiotic resistance genes
- Computer vision plaque assay automated counting and viral lysis halo diameter measurement
- AlphaFold structural prediction modeling phage tail fiber interactions with bacterial lipopolysaccharides
Holding their value
- Designing compassionate-use emergency clinical protocols for terminal septic patients with no antibiotic options
- Evaluating phage bioethics and safety clearances under national pharmaceutical clinical trials rules
- Directing collaborative superbug surveillance partnerships with major Kenyan referral hospital ICUs
- Navigating international Nagoya Protocol material transfer agreements for sovereign African microbial strains
The six things it was scored on
0 to 100 each- Regulatory stakeslowers exposure
- 95
- Digital surfaceraises exposure
- 90
- People and inventionlowers exposure
- 84
- Physical presencelowers exposure
- 48
- Rule bound thinkingraises exposure
- 25
- Routine intensityraises exposure
- 22
Where a named person has to carry the liability.
How much of the work already happens inside software.
Work that needs trust, persuasion or an original idea.
Work that has to happen in a place, with hands.
Decisions that follow a procedure rather than a judgement.
How much of it repeats in the same shape each time.
Task counts
- Tasks recorded
- 15
- Automatable now
- 3
- Still human
- 5
- Displacing
- Manual plaque counting technician,Paper strain catalog filing clerk,Routine phage lysate filtration assistant
- Augmenting
- Phage-host interaction prediction in silico,Automated viral genomic safety screening,Plaque assay computer vision enumeration
- Creating
- Phage Genomics Biobank Architect,Synthetic Phage Tail Fiber Engineer,Antimicrobial Resistance Surveillance Lead
Sources
Behind the ratingGetting in
The routes into the role, credentials, and tools required.
What to study
8 courses- Diploma in Dairy TechnologyKsh 64,120a year
- Craft Certificate in Food Processing and Preservation TechnologyKsh 67,189a year
- Diploma in Analytical BiologyKsh 67,189a year
- Diploma in Analytical ChemistryKsh 67,189a year
- Diploma in Applied BiologyKsh 67,189a year
- Diploma in Food Science and TechnologyKsh 67,189a year
- Diploma in Petroleum and GeoscienceKsh 67,189a year
- Diploma in Science Laboratory TechnologyKsh 67,189a year
How people get in
Microbiology Degree Pathway
4 yearsMedium cost
Bachelor degree in Microbiology, Molecular Biology, or Biotechnology from premier Kenyan universities.
Medical Virology Pathway
2 yearsMedium cost
Microbiologists pursuing postgraduate research in therapeutic bacteriophage isolation and clinical translation.
Industry certifications
2 verified credentialsBiosafety & Biosecurity Officer Certification
IFBAKsh 45,0003 months
Good Laboratory Practice (GLP) Specialist
WHOKsh 30,0002 months
Tools of the trade
5 core toolchains- Geneious Phage Genomics Suite
Bacteriophage Genome Assembly, Annotation & Lysogeny Gene Screening WorkspaceEssentialPaid
- PHASTER Prophage Identifier
Automated Computational Identification & Annotation of Prophage Sequences within Bacterial GenomesEssentialFree
- ÄKTA Pure Chromatography
Fast Protein Liquid Chromatography for Phage Endotoxin & Protein PurificationEssentialPaid
- SnapGene Molecular Suite
In Silico Molecular Cloning & Synthetic Phage Vector Design PlatformRecommendedPaid
- Bio-Rad ChemiDoc Imaging System
Gel Electrophoresis & Plaque Assay Digital Imaging & Enumeration SoftwareRecommendedPaid
Who hires
4 verified employersInterview preparation
3 curated questionsWhy is it strictly mandatory to perform whole-genome sequencing on candidate therapeutic bacteriophages before clinical formulation?
TechnicalSenior
Demonstrate understanding of phage genomics, transduction risks, and patient safety criteria.
A target bacterial clinical strain evolves resistance against a primary therapeutic phage in vitro. How do you respond?
SituationalSenior
Show understanding of bacterial-phage co-evolution and evolutionary trade-off exploitation.
Describe handling a regulatory consultation where medical authorities were hesitant to approve a virus-based compassionate therapy.
BehaviouralMid
Highlight communication clarity, patience, and authoritative scientific advocacy.
Common misconceptions
Bacteriophages are dangerous viruses that infect and sicken human patients.
Bacteriophages are completely harmless to humans; they exclusively hunt, infect, and kill specific bacterial cells.
Phage therapy is an unproven fringe science that has never been tested in medicine.
Phage therapy has been used safely for over a century in Eastern Europe and is now being adopted in mainstream Western hospitals against superbugs.
A single phage cocktail can cure every bacterial infection known to medicine.
Phages are extraordinarily host-specific, requiring precise isolation and matching against a patient specific bacterial strain.
Bacteria can never evolve resistance against predatory bacteriophages.
Bacteria evolve phage resistance, but unlike chemical antibiotics, phages constantly co-evolve and mutate to overcome bacterial defenses.
Extracting phages from hospital sewage makes them dangerously dirty for medical use.
Phages are purified through cesium chloride gradient ultracentrifugation and endotoxin removal columns, achieving sterile cGMP grade purity.
Phage therapy research has zero relevance to East Africa.
Kenya faces alarming rates of multi-drug-resistant hospital superbugs (ESKAPE pathogens) where phages provide a life-saving alternative to failing antibiotics.
Professional bodies & associations
- International Society for Viruses of Microorganisms (ISVM)
- Kenya Society of Microbiologists (KSM)
- Biochemical Society of Kenya (BSK)
- Kenya Medical Research Institute Scientific Advisory Council (KEMRI)
What happens next
How the role evolves from here, and where it leads.
How the role changes
2024-2030Through 2030, phage therapy researchers will advance from academic wastewater sampling to managing accredited national phage biobanks and automated synthetic biology biofoundries that formulate customized personalized phage treatments within 24 hours across East Africa.
- 2024already here
Establishment of Kenya first therapeutic bacteriophage biobank repository at KEMRI.
- 2026already here
Successful compassionate-use clinical trials of lytic phage cocktails treating drug-resistant osteomyelitis.
- 2028projected
Regulatory approval of prophylactic agricultural phage formulations for commercial broiler farms.
- 2030projected
Standardized point-of-care rapid phage susceptibility matching deployed across major Kenyan hospitals.
The near term
2026-2028Low disruption
Escalating antimicrobial resistance in East African hospitals and livestock herds drives clinical isolation and biobanking of therapeutic bacteriophages targeting multi-drug resistant pathogens.
- Tasks automated by 2028
- 20%
- Practitioners augmented
- 74%
- Displacement risk
- 6%
- New roles created
- 34%
- Hospitals partner with research biobanks to supply tailored phage cocktails for untreatable diabetic foot ulcers
- Veterinary poultry farms adopt water-additive phage formulations to eradicate multi-drug resistant Salmonella
- Whole-genome sequencing of phage isolates ensures absence of lysogenic integration or bacterial toxin genes
Market outlook
- Net demand, 2024-2030
- +33%
- Demand
- 87 of 100
- Supply pressure
- 7 of 100
- Balance
- Acute scarcity
- Alarming rise in multi-drug-resistant bacterial infections in Kenyan hospitals exhausting reserve antibiotics
- Establishment of regional phage therapy biobanks and clinical trials at KEMRI and partner universities
- Surging international donor funding for non-antibiotic alternatives to combat global superbugs
- Lack of established regulatory pathways for biological phage cocktails under regional drug authorities
- High costs of cGMP cleanroom facilities required for sterile human clinical injectable production
How to stay ahead
Immediate (Months 1-6)
Isolate lytic bacteriophages from wastewater targeting multidrug-resistant hospital pathogens (Klebsiella, Pseudomonas).
Medium Term (Months 7-18)
Build standardized phage biobanks and characterize phage host ranges and genomic stability for compassionate-use clinical trials.
Long Term (Months 19-36)
Advance to Director of Phage Therapeutics or Principal Antimicrobial Resistance Scientist for national health research bodies.
Master emerging AI workflow automation and predictive analytics tools specific to Phage Therapy Researcher operations
What to learn
- Bacteriophage isolation, plaque purification, and high-titer lysate propagation methodologies
- Phage genomics, lifestyle determination (lytic vs lysogenic), and prophage identification in PHASTER
- Endotoxin removal and lipopolysaccharide (LPS) purification using fast protein liquid chromatography (FPLC)
- Pharmacy and Poisons Board (PPB) compassionate-use experimental therapeutic protocols
- AI assisted workflow orchestration and computerized data management for Phage Therapy Researcher
AI tools worth knowing
PHASTER Prophage Identifier
Priority: Essential
Rapid identification and annotation of prophage sequences within bacterial and viral genomes
Geneious Phage Genomics Suite
Priority: Essential
Assembling phage genomes, identifying open reading frames, and screening against virulence factor databases
ÄKTA Pure Chromatography
Priority: Essential
Preparative ion-exchange and size-exclusion chromatography for sterile phage endotoxin removal
SnapGene Molecular Suite
Priority: Recommended
In-silico restriction enzyme digestion mapping and genetic circuit verification for engineered phages
Where people move next
2 recorded moves- 01Synthetic Biology ScientistStep upModerateexposure 186-12 monthspay +22%76%
- 02Medicinal Mycology SpecialistSidewaysModerateexposure 206-9 monthspay +10%72%
The bar is the share of skills that carry over from this role, so a longer bar is a shorter move. Step up means the destination is more senior; sideways means it sits at the same level.
Kenyan market notes
Spearheaded by institutions like KEMRI and university research labs addressing AMR pathogens identified as high-priority threats by the World Health Organization (WHO) and Africa CDC. Employment opportunities concentrate across major industrial, commercial, and financial hubs including Nairobi, Mombasa, Kisumu, Nakuru, and Eldoret, alongside specialized regional project sites. Remuneration varies between private contracting firms and institutional employers, with certified practitioners enjoying substantial premiums, overtime allowances, and supervisory advancement opportunities. Continuous industrial modernization across Kenya sustains robust demand for certified practitioners with verifiable technical competence and practical operational excellence. Public and private capital investments continue to expand local career opportunities, incentivizing technical upskilling and long-term professional development across Kenyan economic sectors.
Further reading
- PHASTER Web Server for Phage Sequence Identification Documentation
- Bacteriophage Ecology Group Phage Therapy Protocols and Guidelines
- WHO Global Action Plan on Antimicrobial Resistance
- Pharmacy and Poisons Board Compassionate Use Clinical Guidelines
- National Commission for Science, Technology and Innovation (NACOSTI)